1. Nicholson B, Theodorescu D. Molecular Therapeutics in Prostate Cancer. Histol Histopathol 2003;18:275-98. 2. Bostwick DG. Progression of Prostatic Intraepithelial Neoplasia to Early Invasive Adenocarcinoma. Eur Urol 1996;30:145-52. 3. van der Kwast TH, Tetu B. Androgen Receptors in Untreated y Treated Prostatic Intraepithelial Neoplasia. Eur Urol 1996;30:265-8. 4. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular Biology of Prostatic Intraepithelial Neoplasia. Prostate 1996;29:117-34. 5. Bonkhoff H, Remberger K. Diagnostic Criteria and Differential Diagnosis of Prostatic Intraepithelial Neoplasia. Pathologe 1998;19:33-41. 6. Marshall JR. High-Grade Prostatic Intraepithelial Neoplasia As an Exposure Biomarker for Prostate Cancer Chemoprevention Research. IARC Sci Publ 2001;154:191-8. 7. Martin JJ, Martin R, Codesal J, Fraile B, Paniagua R, Santamaria L. Cadmium Chloride-Induced Dysplastic Changes in the Ventral Rat Prostate: an Immunohistochemical and Quantitative Study. Prostate 1-1-2001;46:11-20. 8. Pollard M, Wolter W, Sun L. Diet and the Duration of Testosterone-Dependent Prostate Cancer in Lobund-Wistar Rats. Cancer Lett 28-11-2001;173:127-31. 9. Pollard M, Wolter W. Prevention of Spontaneous Prostate-Related Cancer in Lobund-Wistar Rats by a Soy Protein Isolate/Isoflavone Diet. Prostate 1-10-2000;45:101-5. 10. Morrissey C, Buser A, Scolaro J, O'Sullivan J, Moquin A, Tenniswood M. Changes in Hormone Sensitivity in the Ventral Prostate of Aging Sprague-Dawley Rats. J Androl 2002;23:341-51. 11. Brodin G, ten Dijke P, Funa K, Heldin CH, Landstrom M. Increased Smad Expression and Activation Are Associated With Apoptosis in Normal and Malignant Prostate After Castration. Cancer Res 1-6-1999;59:2731-8. 12. Rao KV, Johnson WD, Bosland MC, Lubet RA, Steele VE, Kelloff GJ, McCormick DL. Chemoprevention of Rat Prostate Carcinogenesis by Early and Delayed Administration of Dehydroepiandrosterone. Cancer Res 1-7-1999;59:3084-9. 13. Bentel JM, Pickering MA, Pollard M, Clements JA, Tilley WD. Androgen Receptor Expression in Primary Prostate Cancers of Lobund-Wistar Rats and in Tumor-Derived Cell Lines. In Vitro Cell Dev.Biol Anim 1999;35:655-62. 14. Shirai T, Takahashi S, Cui L, Futakuchi M, Kato K, Tamano S, Imaida K. Experimental Prostate Carcinogenesis - Rodent Models. Mutat Res 2000;462:219-26. 15. Bosland MC. Use of Animal Models in Defining Efficacy of Chemoprevention Agents Against Prostate Cancer. Eur Urol 1999;35:459-63. 16. Nakamura K, Yasunaga Y, Ko D, Xu LL, Moul JW, Peehl DM, Srivastava S, Rhim JS. Cadmium-Induced Neoplastic Transformation of Human Prostate Epithelial Cells. Int J Oncol 2002;3:543-7. 17. Waalkes MP. Cadmium Carcinogenesis in Review. J Inorg.Biochem 2000;79:241-4. 18. King LM, Banks WA, George WJ. Differential Zinc Transport into Testis and Brain of Cadmium-Sensitive and -Resistant Murine Strains. J Androl 2000;21:656-63. 19. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A. Some New, Simple and Efficient Stereological Methods and Their Use in Pathological Research and Diagnosis. APMIS 1988;96:379-94. 20. Nevalainem MT, Valve EM, Ingleton PM, Harkönen PL. Expression and Hormone Regulation of Prolactin Receptors in Rat Dorsal and Lateral Prostate. Endocrinology 1996;137:3078-88. 21. Hamana T, Kawai K, Serizawa A, Tsutsumi Y, Watanabe K. Immunohistochemical Demonstration of P53 Protein in Colorectal Adenomas and Adenocarcinomas. Reliable Application of the Heat-Induced Antigen Retrieval Method to Formalin-Fixed, Paraffin-Embedded Material. Pathol Int 1994;44:765-70. 22. Ramirez R, Martin R, Martin JJ, Ramirez JR, Paniagua R, Santamaria L. Changes in the Number, Proliferation Rates, and Bcl-2 Protein Immunoexpression of Epithelial and Periductal Cells From Rat Epididymis During Postnatal Development. J Androl 1999;20:702-12. 23. Shirai T, Iwasaki S, Masui T, Mori T, Kato T, Ito N. Enhancing Effect of Cadmium on Rat Ventral Prostate Carcinogenesis Induced by 3,2'-Dimethyl-4-Aminobiphenyl. Jpn J Cancer Res 1993;84:1023-30. 24. Cappello F, Rappa F, David S, Anzalone R, Zummo G. Immunohistochemical Evaluation of PCNA, P53, HSP60, HSP10 and MUC-2 Presence and Expression in Prostate Carcinogenesis. Anticancer Res 2003;23:1325-31. 25. Montironi R, Magi-Galluzzi C, Marina S, Diamanti L. Quantitative Characterization of the Frequency and Location of Cell Proliferation and Death in Prostate Pathology. J Cell Biochem Suppl 1994;19:238-45. 26. Erbersdobler A, Fritz H, Schnoger S, Graefen M, Hammerer P, Huland H, Henke RP. Tumour Grade, Proliferation, Apoptosis, Microvessel Density, P53, and Bcl-2 in Prostate Cancers: Differences Between Tumours Located in the Transition Zone and in the Peripheral Zone. Eur.Urol. 2002;41:40-6. 27. Stattin P, Damber JE, Karlberg L, Nordgren H, Bergh A. Bcl-2 Immunoreactivity in Prostate Tumorigenesis in Relation to Prostatic Intraepithelial Neoplasia, Grade, Hormonal Status, Metastatic Growth and Survival. Urol Res 1996;24:257-64. 28. Sensibar JA. Analysis of Cell Death and Cell Proliferation in Embryonic Stages, Normal Adult, and Aging Prostates in Human and Animals. Microsc Res Tech. 1995;30:342-50.
|